Luteolin-7-rutinoside has both antifungal activities and anti-arthritic, can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection.

Luteolin-7-rutinoside at 40 μg/mL dose give almost the same rate of T cell proliferation as does 20 μg/mL dose of Luteolin-7-rutinoside.?The suppressive activity is dose dependent.?At a dose of 10 μg Luteolin-7-rutinoside (lonicerin)/mL, there is an approximately 47% decrease of the proliferation as compared to proliferation of Luteolin-7-rutinoside treated (control) T cells (p<0.05).?Luteolin-7-rutinoside treatment swifts Th1-Th2 balance away from Th1-toward Th2-type responses.?Luteolin-7-rutinoside inhibits nitric oxide (NO) production from macrophages[1].

20633-84-5

C27H30O15

594.52

Luteolin-7-rutinoside

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years